Antibiotic gatifloxacin (Tequin) pulled from market

content provided by

Antibiotic gatifloxacin (Tequin) pulled from market

The manufacturer of the antibiotic gatifloxacin (Tequin) has halted production of the drug.

What happened?The antibiotic Tequin, the subject of concerns about side effects, is being taken off the market.

Although manufacturer Bristol-Myers Squibb is pulling the drug gatifloxacin (Tequin), current stocks of the antibiotic are still available. However, no additional gatifloxacin will be made.

Gatifloxacin is in a class of popular broad-spectrum antibiotics called fluoroquinolones. The antibiotic has been linked to fluctuations in blood sugar severe enough to require hospitalization. Other adverse effects, including kidney failure and liver problems, have led to the withdrawal or restriction of several other drugs from the same class of antibiotics.

Gatifloxacin has been used to treat many different bacterial infections, including pneumonia, bronchitis, sinus infections, respiratory tract infections, urinary tract infections and certain sexually transmitted diseases. Other antibiotics in the same class include ciprofloxacin (Cipro, others) and levofloxacin (Levaquin, others).

What does this mean to you? If you're taking gatifloxacin, ask your doctor about an alternate antibiotic — especially if you have diabetes, a severe infection or other factors that increase your risk of blood sugar fluctuations. Other antibiotics are available for every approved use for gatifloxacin.

Last Updated: 05/03/2006
© 1998-2016 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "," "Mayo Clinic Health Information," "Reliable information for a healthier life" and the triple-shield Mayo logo are trademarks of Mayo Foundation for Medical Education and Research.

Terms and conditions of use


Bookmark and Share   E-Mail Page   Printer Friendly Version